Search

Displaying results 2051 - 2060 of 10000 in total
  1. Drug

    Nonivamide

    go.drugbank.com/drugs/DB11324
    Approved

    Nonivamide has also been studied for its anti-inflammatory properties, as well as in fat loss therapies and has demonstrated promising results [L2643], [A32888], [A32886], [A32884]. … This drug has been studied in combination with Nicarboxil in the treatment of lower back pain [L2642].

    Mixtures: Nonivamid + Nicoboxil Zentiva 4 mg/g + 25 mg/g Salbe
  2. Drug

    Lubiprostone

    go.drugbank.com/drugs/DB01046
    ApprovedInvestigational

    Lubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastroi...

    Products: MOVIPROST 24 MCG, MOVIPROST ® 8 MCG
  3. Drug

    JTC-801 free base

    go.drugbank.com/drugs/DB17033
    Experimental

    An antagonist of nociceptin receptor and analgesic agent, evaluated for its use in cancer treatment.

    Synonyms: JTC-801 free base
  4. Drug

    SKF-96365 free base

    go.drugbank.com/drugs/DB17054
    Experimental

    SKF-96365 is a receptor-mediated calcium entry (RMCE) inhibitor structurally different from other calcium antagonists.

    Synonyms: SKF-96365 free base
  5. Drug

    3D-185 free base

    go.drugbank.com/drugs/DB17395
    Experimental

    Synonyms: 3D-185 free base
  6. Drug

    CPP-115 free base

    go.drugbank.com/drugs/DB17919
    Investigational

    Synonyms: CPP-115 free base
  7. Drug

    KW-2450 free base

    go.drugbank.com/drugs/DB16637
    Investigational

  8. Drug

    SEL120-34A free base

    go.drugbank.com/drugs/DB18107
    Investigational

    Salts: SEL-120Synonyms: Cdk8-in-2 free base, SEL120-34A free base
  9. Drug

    PF-03049423 FREE BASE

    go.drugbank.com/drugs/DB33809
    Investigational

    Categories: Phosphodiesterase 5 Inhibitors
  10. Drug

    Doxercalciferol

    go.drugbank.com/drugs/DB06410
    ApprovedInvestigational

    Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients

    Synonyms: (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diolProducts: HECTOROL® CAPSULAS 0.5 MCG, HECTOROL CÁPSULAS BLANDAS 2.5 MCG